Opening statements end in a historic trial testing whether Big Pharma can be held accountable for the opioid epidemic
A historic Oklahoma trial that will test whether a state can make a pharmaceutical company pay for the opioid epidemic will resume Wednesday with the testimony of the father of Austin Box, a 22-year-old linebacker for the Sooners who died of an overdose.
Oklahoma Attorney General Mike Hunter in opening statements Tuesday accused drugmakers of a"cynical, deceitful, multimillion-dollar brainwashing campaign to establish opioid analgesics as the magic drug." The trial is expected to lay a road map for other states and municipalities in holding drugmakers accountable for what Hunter told the court was"the worst man-made public health crisis in the history of our country and the state -- the prescription opioid epidemic.
Hunter said the public deserves to know whether the company deliberately targeted children, the elderly and veterans for opioid painkillers, and whether it blocked legislation and regulatory action aimed at limiting opioid availability. In its statement, Johnson & Johnson said the company"did not market opioids to children, and the State's suggestion to the contrary is false and reckless.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Historic trial tests whether big pharma can be held accountable for opioid epidemicThe Oklahoma trial is the first major trial of nearly 2,000 cases around the country in which states, cities and hard-hit local municipalities are seeking to hold opioid makers accountable for the epidemic that has left hundreds of thousands of Americans dead, and strapped resources in every state.
Leer más »
Google sister-company Verily is teaming with big pharma on clinical trialsVerily, Alphabet's health and life sciences division, is moving into the clinical trials market. It just announced strategic alliances with Novartis, Sanofi, Otsuka and Pfizer.
Leer más »
Can big names and big money make the Grand a great civic place?After years of starts and stops, the Grand is showing signs of life. It remains to be seen if the $1-billion project can be a commercial and civic success.
Leer más »
Nation's first opioid trial could set precedent for massive pharma payoutsA trial kicking off in Norman, Oklahoma, on Tuesday will provide an unprecedented examination of how the country spiraled into a devastating opioid epidemic
Leer más »
Congressional report: Purdue Pharma influenced World Health Organization’s opioid guidelinesA bipartisan investigation alleges the international group took directions from the drugmaker’s marketing and sales strategies.
Leer más »
U.N. agency is accused of helping Purdue Pharma make opioid epidemic globalTwo members of Congress accused the World Health Organization of helping Purdue Pharma use the same “propaganda campaign” that fueled the opioid epidemic in the U.S. to expand drug sales internationally.
Leer más »
Exclusive: JPMorgan cuts ties with OxyContin maker Purdue Pharma - sourcesJPMorgan Chase & Co has cut ties with Purdue Pharma LP over the OxyContin maker&...
Leer más »
JP Morgan cuts ties with OxyContin maker Purdue PharmaJ.P. Morgan Chase has cut ties with Purdue Pharma LP over the OxyContin maker's alleged role in the U.S. opioid crisis, forcing it to find a new bank to manage cash and bill payments.
Leer más »
Dispensed: Medicare Advantage's surprising success, Nurx's rebound, and a new startup trying to upend how you get mental healthcare at workWelcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
Leer más »